Market Overview

Benzinga's Top Initiations

Benzinga's Top Initiations
Related ALB
Top 4 Mid-Cap Stocks In The Specialty Chemicals Industry With The Highest ROI
Earnings Scheduled For October 22, 2014
Related INSY
UPDATE: Insys Therapeutics Receives FDA Orphan Drug Designation For Its Pharmaceutical Cannabidiol As A Potential Treatment For Pediatric Schizophrenia
Earnings Scheduled For November 11, 2014
Making Money With Charles Payne: 12/4/14 (Fox Business)

Analysts at Topeka Capital initiated coverage on shares of Albemarle (NYSE: ALB) with a “hold” rating. The target price for Albemarle is set to $67. Albemarle's shares closed at $61.88 yesterday.

Oppenheimer initiated coverage on shares of Insys Therapeutics (NASDAQ: INSY) with an “outperform” rating. The target price for Insys Therapeutics is set to $23. Insys Therapeutics's stock closed at $16.05 yesterday.

SunTrust Robinson Humphrey initiated coverage on shares of Goodrich Petroleum (NYSE: GDP) with a “buy” rating. The target price for Goodrich Petroleum is set to $25. Goodrich Petroleum's shares closed at $17.97 yesterday.

Analysts at Credit Suisse initiated coverage on shares of Sunesis Pharmaceuticals (NASDAQ: SNSS) with a “buy” rating. The target price for Sunesis Pharmaceuticals is set to $25. Sunesis's shares closed at $5.40 yesterday.

Latest Ratings for ALB

DateFirmActionFromTo
Dec 2014NomuraInitiates Coverage onBuy
Nov 2014JefferiesMaintainsBuy
Oct 2014Deutsche BankUpgradesHoldBuy

View More Analyst Ratings for ALB
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (ALB + GDP)

Around the Web, We're Loving...

Get Benzinga's Newsletters